Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of Probiotics and Semaglutide on Body Weight and Metabolic Homeostasis
NCT06989177Recruiting
- Sponsor
- Chinese Academy of Sciences
- Start
- Jun 2025
- Primary completion
- Dec 2026
- Modality
- Peptides, Recombinant Proteins and Enzymes, Live Biotherapeutic Products
- Countries
- 1
01
Overview
Randomised trial of Lactobacillus paracasei LC-19 and semaglutide in obesity (4 arms), sponsored by Chinese Academy of Sciences. Primary endpoint: Change in Body Weight at 12 weeks. Started Jun 2025; status: recruiting.
02
Drugs
Lactobacillus paracasei LC-19semaglutide
03
Conditions
obesity
Beyond the preview
Go deeper on NCT06989177.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06989177.